Documento de consenso de poliquistosis renal autosómica dominante del grupo de trabajo de enfermedades hereditarias de la Sociedad Española de Nefrología. Revisión 2020-Reference-Cited by-同舟云学术

Documento de consenso de poliquistosis renal autosómica dominante del grupo de trabajo de enfermedades hereditarias de la Sociedad Española de Nefrología. Revisión 2020

Published:2021-10 Issue: Volume: Page:
ISSN:0211-6995
Container-title:Nefrología
language:es
Short-container-title:Nefrología

Author:

Ars Elisabet,Bernis Carmen,Fraga Gloria,Furlano Mónica,Martínez Víctor,Martins Judith,Ortiz Alberto,Pérez-Gómez Maria Vanessa,Rodríguez-Pérez José Carlos,Sans Laia,Torra Roser

Funder

ISCIII

Publisher

Elsevier BV

Subject

Nephrology

Reference128 articles.

1. Epidemiology of adult polycystic kidney disease, Olmsted County Minnesota: 1935-1980;Garcia Iglesias;Am J Kidney Dis.,1983

2. Epidemiology of autosomal dominant polycystic kidney disease in Olmsted County;Suwabe;Clin J Am Soc Nephrol.,2020

3. Epidemiology of autosomal-dominant polycystic kidney disease: An in-depth clinical study for south-western Germany;Neumann;Nephrol Dial Transplant.,2013

4. Overview of autosomal dominant polycystic kidney disease in the south of Spain;Morales Garcia;Nefrologia.,2018

5. Renal replacement therapy in ADPKD patients: A 25-year survey based on the Catalan registry;Martínez;BMC Nephrol.,2013

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term effectiveness and safety of tolvaptan in autosomal dominant polycystic kidney disease;Medicina Clínica;2024-07

2. Long-term effectiveness and safety of tolvaptan in autosomal dominant polycystic kidney disease;Medicina Clínica (English Edition);2024-07

3. Measured and Estimated Glomerular Filtration Rate to Evaluate Rapid Progression and Changes over Time in Autosomal Polycystic Kidney Disease: Potential Impact on Therapeutic Decision-Making;International Journal of Molecular Sciences;2024-05-05

4. Quistes hepáticos;Medicine - Programa de Formación Médica Continuada Acreditado;2024-04

5. Compassionate use of tolvaptan in acquired megacolon secondary to autosomal dominant polycystic kidney disease (ADPKD);Nefrología (English Edition);2024-03